A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Barclays Maintains Illumina (ILMN) Underweight Recommendation - Nasdaq
Barclays Maintains Illumina (ILMN) Underweight Recommendation Nasdaq
Illumina advances personalized cancer care with new pharma development partnerships - PR Newswire
Illumina advances personalized cancer care with new pharma development partnerships PR Newswire
Illumina sued by rival Element over gene-sequencing technology - Reuters
Illumina sued by rival Element over gene-sequencing technology Reuters
Hardening Software Security: DOJ’s Civil Cyber Fraud Settlements Continue to Illumina[te] the Importance of Cybersecurity - Crowell & Moring LLP
Hardening Software Security: DOJ’s Civil Cyber Fraud Settlements Continue to Illumina[te] the Importance of Cybersecurity Crowell & Moring LLP
DOJ reaches $9.8 million settlement with Illumina over cyber whistleblower claims - Cybersecurity Dive
DOJ reaches $9.8 million settlement with Illumina over cyber whistleblower claims Cybersecurity Dive
Illumina Sues Element Biosciences, Alleging Infringement of Flow Cell, Imaging Patents - GEN - Genetic Engineering and Biotechnology News
Illumina Sues Element Biosciences, Alleging Infringement of Flow Cell, Imaging Patents GEN - Genetic Engineering and Biotechnology News
Illumina addresses recent developments in China - PR Newswire
Illumina addresses recent developments in China PR Newswire
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page